SCHEMBL377073

SCHEMBL377073

C[C](C(N)=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.62
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
NPSR1 Q6W5P4 1/20 0.54
SRD5A2 P31213 1/20 0.53
ALDH1A1 P00352 3/20 0.51
POLB P06746 1/20 0.51
PTGS1 P23219 3/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
ADORA1 P30542 1/20 0.50
HSD17B10 Q99714 1/20 0.50
P2RX1 P51575 1/20 0.50
LMNA P02545 1/20 0.50
GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3726477 0.83 DHODH (0.59) CES2PTGS1LMNAGAA
Acetic Acid SCHEMBL10340449 0.83 CES2 (0.62) CES2MEN1KMT2ANPSR1SRD5A2
SCHEMBL27621589 0.82 CES2 (0.71) CES2NPSR1SRD5A2POLBPTGS1
SCHEMBL39834 0.82 CES2 (0.71) CES2MEN1KMT2ANPSR1SRD5A2
SCHEMBL30093723 0.82 CES2 (0.71) CES2MEN1KMT2ANPSR1SRD5A2
SCHEMBL171684 0.82 CES2 (0.71) CES2NPSR1SRD5A2POLBPTGS1
Hydrochloric Acid SCHEMBL4372373 0.80 CES2 (0.69) CES2NPSR1SRD5A2POLBPTGS1
Water SCHEMBL28050254 0.80 CES2 (0.69) CES2NPSR1SRD5A2POLBPTGS1
Benzene SCHEMBL28007804 0.80 CES2 (0.69) CES2KMT2ANPSR1SRD5A2POLB
Hydrochloric Acid SCHEMBL1267321 0.80 CES2 (0.69) CES2NPSR1SRD5A2POLBPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408754-A1 Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105750-A1 TRIAZOLE DERIVATIVES AS VASOPRESSIN-RECEPTOR INHIBITORS FOR TREATING CARDIAC INSUFFICIENCY BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed